Display options
Share it on

JHEP Rep. 2021 Aug 12;3(5):100351. doi: 10.1016/j.jhepr.2021.100351. eCollection 2021 Oct.

Excellent outcomes with liver transplantation in hepatopulmonary syndrome across pre-transplant PaO.

JHEP reports : innovation in hepatology

Zakiyah Kadry, Eric Schaefer, Karen Krok, Alison Faust, Jonathan Gibson Stine, Ian Roy Schreibman, Dmitri Bezinover, Thomas Roberts Riley

Affiliations

  1. Division of Transplantation, Department of Surgery, Penn State College of Medicine, Hershey, PA, USA.
  2. Department of Public Health Sciences, Penn State College of Medicine, Hershey, PA, USA.
  3. Division of Gastroenterology and Hepatology, Department of Medicine, Penn State College of Medicine, Hershey, PA, USA.
  4. Department of Anesthesiology, Penn State College of Medicine, Hershey, PA, USA.

PMID: 34604726 PMCID: PMC8473556 DOI: 10.1016/j.jhepr.2021.100351

Abstract

BACKGROUND & AIMS: Significantly worse survival has been reported in patients with hepatopulmonary syndrome (HPS) and partial pressure of arterial oxygen (PaO

METHODS: A retrospective analysis of 1,152 HPS candidates listed with an approved HPS model for end-stage liver disease (MELD) exception was performed. A Fine and Gray competing risks model was utilised to evaluate pre-transplant outcomes for PaO

RESULTS: Patients with a PaO

CONCLUSIONS: Patients with a PaO

LAY SUMMARY: A total of 1,152 patients with hepatopulmonary syndrome listed for liver transplant were analysed. Patients with a low PaO

© 2021 The Authors.

Keywords: CIF, cumulative incidence function; ECMO, extracorporeal membrane oxygenation; HPS, hepatopulmonary syndrome; HR, hazard ratio; Hepatopulmonary syndrome; Hypoxia; Liver transplantation; MELD, model for end-stage liver disease; NASH, non-alcoholic steatohepatitis; OPTN, Organ Procurement and Transplant Network; POPH, portopulmonary hypertension; PaO2, partial pressure of arterial oxygen; STAR, Standard Transplant Analysis and Research; UNOS, United Network for Organ Sharing

Conflict of interest statement

The authors have no conflicts of interest or financial disclosures to make. Please refer to the accompanying ICMJE disclosure forms for further details.

References

  1. J Hepatobiliary Pancreat Sci. 2019 Jul;26(7):292-299 - PubMed
  2. Pediatr Transplant. 2012 Nov;16(7):E281-5 - PubMed
  3. Liver Transpl. 2015 Nov;21(11):1355-64 - PubMed
  4. Gastroenterology. 2006 Jul;131(1):69-75 - PubMed
  5. Hepatology. 2005 May;41(5):1122-9 - PubMed
  6. Stat Med. 2007 Oct 30;26(24):4505-19 - PubMed
  7. Liver Transpl. 2014 Sep;20(9):1141-4 - PubMed
  8. Gastroenterology. 2014 May;146(5):1256-65.e1 - PubMed
  9. Eur Respir J. 2019 Jan 31;53(2): - PubMed
  10. Hepatology. 2013 Jun;57(6):2427-35 - PubMed
  11. Hepatol Res. 2018 Mar;48(4):225-232 - PubMed
  12. Gastroenterology. 2003 Oct;125(4):1042-52 - PubMed
  13. Gastroenterology. 2008 Oct;135(4):1168-75 - PubMed
  14. Pediatr Transplant. 2017 Nov;21(7): - PubMed
  15. World J Gastroenterol. 2018 Mar 28;24(12):1285-1298 - PubMed
  16. Liver Transpl. 2008 Jul;14(7):966-70 - PubMed
  17. CMAJ. 2018 Feb 26;190(8):E223 - PubMed
  18. Int J Artif Organs. 2021 Jan 21;:391398821989067 - PubMed
  19. Am J Transplant. 2010 Feb;10(2):354-63 - PubMed
  20. Transplantation. 2003 May 15;75(9):1482-9; discussion 1446-7 - PubMed
  21. Am J Transplant. 2015 Apr;15(4):903-13 - PubMed
  22. Clin Gastroenterol Hepatol. 2007 Jun;5(6):749-54 - PubMed
  23. Transplantation. 2016 Jul;100(7):1440-52 - PubMed
  24. Clin Chest Med. 2017 Dec;38(4):785-795 - PubMed
  25. Int J Artif Organs. 2015 Mar;38(3):170-2 - PubMed
  26. Transplantation. 1993 Jan;55(1):212-4 - PubMed
  27. Liver Transpl. 2014 Feb;20(2):182-90 - PubMed
  28. Liver Transpl. 2006 Dec;12(12 Suppl 3):S105-7 - PubMed
  29. Crit Care. 2011;15(5):R234 - PubMed
  30. Am J Transplant. 2008 May;8(5):954-64 - PubMed
  31. Respir Med. 2013 Jul;107(7):1030-6 - PubMed
  32. Echocardiography. 2006 Apr;23(4):271-8 - PubMed

Publication Types